Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis

Pieter Martens1, Sanjeeb Bhattacharya1, Joshua Longinow2

  • 1Kaufman Center for Heart Failure Treatment and Recovery, Heart Vascular and Thoracic Institute, Cleveland Clinic, OH (P.M., S.B., L.I., M.J., M.H., W.H.W.T.).

Insights

Cardiac amyloidosis (CA) shows abnormal hemodynamics, but higher thresholds for filling pressures predict outcomes. Reduced cardiac index (CI) is the strongest predictor of adverse events and functional decline in CA patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Amyloidosis Research

Background:

  • Cardiac amyloidosis (CA) subtypes lack established prognostic hemodynamic cutoffs.
  • Understanding hemodynamic profiles is crucial for managing CA progression.

Purpose of the Study:

  • To evaluate the prognostic relevance of traditional hemodynamic cutoffs in light chain (LC) and transthyretin (TTR) CA.
  • To identify key hemodynamic predictors of adverse outcomes in CA patients.

Main Methods:

  • Retrospective analysis of 469 CA patients undergoing right heart catheterization.
  • Assessed classic hemodynamic cutoffs (cardiac index, filling pressures, pulmonary artery pressure) against composite endpoints (transplant/death, HF admissions).

Main Results:

  • Elevated right atrial pressure, pulmonary capillary wedge pressure, and pulmonary hypertension were common (69-79%).
  • Classic cutoffs for right atrial pressure and mean pulmonary artery pressure were not significant predictors.
  • Higher thresholds (14 mm Hg for right atrial pressure, 35 mm Hg for mean pulmonary artery pressure) improved risk prediction.
  • Reduced cardiac index (CI) in 55% of patients was the strongest predictor of adverse outcomes and functional capacity.
  • Reduced CI independently predicted risk beyond established scoring systems (Mayo, NAC).

Conclusions:

  • Hemodynamic abnormalities are prevalent in CA, but prognostic thresholds for filling pressures differ from classic values.
  • Cardiac index (CI) is the most significant hemodynamic predictor of outcomes and functional status in cardiac amyloidosis.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
25
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
16
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
15
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29